FDA.reportPublic FDA data

Yeztugo 927 MG 2-Vial Kit

RxCUI
2717203
RxNorm name
Yeztugo 927 MG 2-Vial Kit
Display name
Yeztugo 927 MG 2-Vial Kit
Full name
Yeztugo 927 MG 2-Vial Kit
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:49

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YeztugoLENACAPAVIR SODIUMGilead Sciences, Inc.1c241af1-ce62-4b0a-9eb7-f6b626174f012026-08-11Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2717203

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
1c241af1-ce62-4b0a-9eb7-f6b626174f01{2 (1.5 ML lenacapavir 309 MG/ML Injection [Yeztugo]) } Pack [Yeztugo 927 MG Kit] [BPCK] · Yeztugo 927 MG 2-Vial Kit [PSN] · Yeztugo 927 MG 2-Vial Kit [SY]34These highlights do not include all the information needed to use YEZTUGO safely and effectively. See full prescribing information for YEZTUGO. YEZTUGO ® (lenacapavir) tablets, for oral use YEZTUGO ® (lenacapavir) injection, for subcutaneous use Initial U.S. Approval: 202220260212